Search

Your search keyword '"Puberty, Delayed drug therapy"' showing total 307 results

Search Constraints

Start Over You searched for: Descriptor "Puberty, Delayed drug therapy" Remove constraint Descriptor: "Puberty, Delayed drug therapy"
307 results on '"Puberty, Delayed drug therapy"'

Search Results

1. A Current Perspective on Delayed Puberty and Its Management

2. Long-term Growth Hormone Therapy in a Patient with IGF1R Deletion Accompanied by Delayed Puberty and Central Hypothyroidism

3. Prevalence and Factors Associated With Delayed Puberty Among Adolescents on Boosted Protease Inhibitor-based Second-line Antiretroviral Therapy: A Cross-sectional Study at a Pediatric Infectious Diseases Clinic in Uganda.

4. Approaches to Identify Factors Associated with Pubertal Timing in Self-Limited Delayed Puberty.

5. Considerations when treating male pubertal delay pharmacologically.

6. Efficacy of short-term induction therapy with low-dose testosterone as a diagnostic tool in the workup of delayed growth and puberty in boys.

7. Insulin-like peptide 3 (INSL3) in congenital hypogonadotrophic hypogonadism (CHH) in boys with delayed puberty and adult men.

8. Health-related quality of life in boys with constitutional delay of growth and puberty.

9. Hypogonadism in adolescent girls: treatment and long-term effects.

10. New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature.

11. Efficacy and Safety of Letrozole in the Management of Constitutional Delay in Growth and Puberty: A Systematic Review and Meta-analysis

12. Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline.

13. Delayed puberty in boys in central Sweden: an observational study on diagnosing and management in clinical practice.

14. Hypogonadism in male and female: which is the best treatment?

15. Circulating miR-30b levels increase during male puberty.

16. Pubertal induction in adolescents with DMD is associated with high satisfaction, gonadotropin release and increased muscle contractile surface area.

17. Delayed puberty.

18. Delayed and Precocious Puberty: Genetic Underpinnings and Treatments.

19. Anti-Müllerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone.

20. Effect of Testosterone Treatment for Delayed Puberty in Duchenne Muscular Dystrophy.

21. Effects of the Timing of Sex-Steroid Exposure in Adolescence on Adult Health Outcomes.

22. Letrozole Effect on Final Height of Patients with Constitutional Delay of Growth and Puberty.

23. Effects of Estrogen Therapies on Outcomes in Turner Syndrome: Assessment of Induction of Puberty and Adult Estrogen Use.

24. Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy.

25. Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial.

26. Gonadotropin replacement in male thalassemia major patients with arrested puberty and acquired hypogonadotropic hypogonadism (AAH): preliminary results and potential factors affecting induction of spermatogenesis.

27. Testosterone Therapy in Adolescent Boys: The Need for a Structured Approach.

28. Diversity of Pubertal Development in Cartilage-Hair Hypoplasia; Two Illustrative Cases.

29. Management of hypogonadism from birth to adolescence.

30. Divergent responses to kisspeptin in children with delayed puberty.

31. Use of testosterone gel compared to intramuscular formulation for puberty induction in males with constitutional delay of growth and puberty: a preliminary study.

32. Single-Centre Experience of Testosterone Therapy for Boys with Hypogonadism.

33. Pubertal development in children with chronic kidney disease.

34. Transdermal testosterone gel for induction and continuation of puberty in adolescent boys with hepatic dysfunction.

35. The measurement of urinary gonadotropins for assessment and management of pubertal disorder.

36. Short stature and pubertal delay in Duchenne muscular dystrophy.

37. Sex Steroid Replacement Therapy in Female Hypogonadism from Childhood to Young Adulthood.

38. Different Medications for Hypogonadotropic Hypogonadism.

39. Sex Steroid and Gonadotropin Treatment in Male Delayed Puberty.

40. Fertility Issues for Patients with Hypogonadotropic Causes of Delayed Puberty.

41. Testosterone Treatment of Pubertal Delay in Duchenne Muscular Dystrophy.

42. [Puberty and cystic fibrosis].

43. Evaluation of 451 Danish boys with delayed puberty: diagnostic use of a new puberty nomogram and effects of oral testosterone therapy.

44. GH therapy in transition age: state of the art and future perspectives.

45. Growth problems in children with IBD.

46. Growth hormone treatment in a patient with Hurler-Scheie syndrome.

47. Treatment of hypogonadism in males.

48. Pathological fractures in paediatric patients with inflammatory bowel disease.

49. Pubertal induction in adult males with isolated hypogonadotropic hypogonadism using long-acting intramuscular testosterone undecanoate 1-g depot (Nebido).

50. A multicenter, open-label, observational study of testosterone gel (1%) in the treatment of adolescent boys with klinefelter syndrome or anorchia.

Catalog

Books, media, physical & digital resources